SCHEDULE 13G/A: Statement of Beneficial Ownership by Certain Investors
Published on
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 | |
SCHEDULE 13G | |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
| |
(Amendment No. 1)
| |
RenovoRx, Inc. (Name of Issuer) | |
Common Stock (Title of Class of Securities) | |
| |
09/30/2026 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP Number(s): | 75989R107 |
| 1 | Names of Reporting Persons
BOSTON SCIENTIFIC CORP | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
0.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
RenovoRx, Inc. |
| (b) | Address of issuer's principal executive offices:
2570 West El Camino Real, Suite 640, Mountain View, CA 94040 |
| Item 2. | |
| (a) | Name of person filing:
Boston Scientific Corporation |
| (b) | Address or principal business office or, if none, residence:
300 Boston Scientific Way, Marlborough, MA 01752 |
| (c) | Citizenship:
Delaware |
| (d) | Title of class of securities:
Common Stock |
| (e) | CUSIP No.:
75989R107 |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
0
This Amendment No. 1 (this "Amendment") amends in its entirety the statement on Schedule 13G originally filed on February 10, 2022 by Boston Scientific Corporation (the "Reporting Person"). In August 2026, the Reporting Person sold 543,971 shares of common stock, $0.0001 par value, of RenovoRx, Inc. (the "Issuer"). This Amendment is being filed to disclose that as of September 30, 2026, the Reporting Person has ceased to be the beneficial owner of more than 5% of the outstanding shares of common stock of the Issuer. This Amendment is the final amendment to the Schedule 13G and constitutes an exit filing for the Reporting Person. |
| (b) | Percent of class:
0 %
|
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
0 | |
| (ii) Shared power to vote or to direct the vote:
0 | |
| (iii) Sole power to dispose or to direct the disposition of:
0 | |
| (iv) Shared power to dispose or to direct the disposition of:
0 | |
| Item 5. | Ownership of 5 Percent or Less of a Class. |
|
Ownership of 5 percent or less of a class
| |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|